city New Delhi India city Hyderabad covid-19 vaccine Health city New Delhi India city Hyderabad

DGCI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18

Reading now: 654
www.livemint.com

New Delhi: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its 'Made in India' COVID-19 vaccine on children aged between 5 and 18 years with certain conditions, sources said.

The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A  Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of Corbevax Vaccine in Children and Adolescents', a source said.

The trial will be conducted across 10 sites in the country. The DCGI's permission was given based on the recommendations by the Subject Expert Committee (SEC) on

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA